Welcome to NOVOCIB

NOVOCIB is a French biotechnology company which has specialized in the study of nucleotides and nucleosides metabolism. We produce recombinant enzymes of purine metabolism and develop enzymatic assays and analytical services for the Drug Discovery, Life Science and Food Quality control..

Drug Discovery
Life Science
Food Quality Control
NEW!

• ADK Screening Assay Kit
A therapeutic target for new analgesic and anti-inflammatory drugs acting by non-opiod, non-NSAID-mediated mechanism

S. aureus IMPDH vs. Human IMPDH Screening Assay Kit
New target for the search of novel antibiotics efficient against bacterial resistance

• Rare enzymes of Purine Metabolism
Targets for the treatment of immunologic disorders and cancers: IMPDH Type II, PNP...

• Pharmacology of Nucleoside analogues
Nucleoside Kinase Enzymes catalyzing rate-limiting steps of the activation of antiviral and anticancer NAs

• Screening assays
In vitro inhibition assays
Whole Cell assays

• HPRT Assay Kit
Fast and easy measurement of HPRT (hypoxanthine-guanine phosphoribosyl transferase) activity by spectrophotometry.

• NADH Bioluminescence Assay Kit
Rapid and ultrasensitive NAD(P)H Assay based on bacterial luciferase (Photobacterium phosphoreum)

• FMN Reductase (rec., E.coli)

• Recombinant enzymes of Nucleotide metabolism

• Nucleoside & nucleotide analysis
Nucleotide profiling, Customized services

NEW!
  

• Fish (& Meat) Freshness measurement Assay Kits
Fast and easy-to-use enzymatic Kits for quantification of ATP degradation products (%IMP or "K-value", %Hx) in Fish & Meat.

• Baby Milk analysis
Nucleotide quantification in Baby Milk powder

Recent events
September 16-18, 2011
Dr Larissa Balakireva, CEO & Founder of NovoCIB, was awarded with the Trophy of "Femmes en Or 2011"

NOVOCIB is certified by the French Ministry of Higher Education and Research as a "Research Tax Credit" (Crédit Impôt Recherche - CIR) company. This agreement allows NOVOCIB's clients who are subject to corporate income tax in France to benefit from a significant tax credit upon R&D expenditures outsourced to NovoCIB.
To know more:
French Ministry of Research (in French)
Press Release
^Top of Page